RetinalGenix Technologies

RetinalGenix Technologies EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of RetinalGenix Technologies (RTGN) as of Nov 2, 2026 is -11,523.17 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -28,883.90 % — a change of -60.11% (higher).

EBIT/Assets

-11,523.17 %

YoY

-60.11%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of RetinalGenix Technologies is 2025 -11,523.17 % . Operating Income to Assets Ratio (EBIT/Assets) of RetinalGenix Technologies was 2024 -28,883.90 % . It decreases by -60.11% higher compared to the previous year.

The RetinalGenix Technologies EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2020
-3,402.36 USD
Jan 1, 2021
-43,999.90 USD
Jan 1, 2022
-1.33 M USD
Jan 1, 2023
-1.34 M USD
Jan 1, 2024
-28,883.90 USD
Jan 1, 2025
-11,523.17 USD
The RetinalGenix Technologies EBIT/Assets history
YEAREBIT/AssetsYoY
-11,523.17 %-60.11%
-28,883.90 %-97.84%
-1.34 M %+0.63%
-1.33 M %+2,921.69%
-43,999.90 %+1,193.22%
-3,402.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

RetinalGenix Technologies Stock analysis

What does RetinalGenix Technologies do? RetinalGenix Technologies Inc, based in Petaluma, California, is a medical device company focused on ocular health. The company develops innovative solutions for screening, monitoring, diagnosing, and treating sight-threatening disorders, particularly diabetic retinopathy and maculopathy. Its key products include the Retinal Imaging Screening Device, a portable system offering a 200-degree field of view without pupil dilation, and RetinalCam, a home monitoring device with 24/7 physician access for real-time communication. Both devices aim to address vision loss and blindness through advanced imaging technology. RetinalGenix Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RetinalGenix Technologies stock

Operating Income to Assets Ratio (EBIT/Assets) of RetinalGenix Technologies is -11,523.17 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of RetinalGenix Technologies changed from -28,883.90 % to -11,523.17 %, representing a -60.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) RetinalGenix Technologies since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s RetinalGenix Technologies with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — RetinalGenix Technologies

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — RetinalGenix Technologies